Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-(2-METHOXY-BENZYL)-1H-PYRROLE-2-CARBALDEHYDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

876892-41-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 876892-41-0 Structure
  • Basic information

    1. Product Name: 1-(2-METHOXY-BENZYL)-1H-PYRROLE-2-CARBALDEHYDE
    2. Synonyms: 1-(2-METHOXY-BENZYL)-1H-PYRROLE-2-CARBALDEHYDE;ASINEX-REAG BAS 11881234
    3. CAS NO:876892-41-0
    4. Molecular Formula: C13H13NO2
    5. Molecular Weight: 215.25
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 876892-41-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-(2-METHOXY-BENZYL)-1H-PYRROLE-2-CARBALDEHYDE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-(2-METHOXY-BENZYL)-1H-PYRROLE-2-CARBALDEHYDE(876892-41-0)
    11. EPA Substance Registry System: 1-(2-METHOXY-BENZYL)-1H-PYRROLE-2-CARBALDEHYDE(876892-41-0)
  • Safety Data

    1. Hazard Codes: Xi,Xn
    2. Statements: 22-36
    3. Safety Statements: 26
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 876892-41-0(Hazardous Substances Data)

876892-41-0 Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 13 carbon (C) atoms, 13 hydrogen (H) atoms, 1 nitrogen (N) atom, and 2 oxygen (O) atoms.

Explanation

The compound is derived from a pyrrole, which is a five-membered heterocyclic ring containing one nitrogen atom. It has a benzyl group (C6H5-CH2-) attached to the nitrogen atom and a methoxy group (-O-CH3) attached to the benzene ring.

Explanation

Due to its unique structure and potential pharmacological properties, this compound may be useful in the synthesis of various organic compounds and could be explored for its potential applications in the field of medicinal chemistry.

Explanation

The compound can be used as a starting material or building block in the synthesis of other complex organic molecules, which may have various applications in different fields.

Explanation

More research is needed to fully comprehend the compound's potential applications, pharmacological properties, and effects on biological systems. This will help in determining its suitability for specific uses in organic synthesis and medicinal chemistry.

Chemical Structure

Pyrrole derivative with a benzyl group and a methoxy group

Potential Applications

Organic synthesis and medicinal chemistry

Building Block

Synthesis of other organic compounds

Further Studies

Required to understand potential uses and effects

Check Digit Verification of cas no

The CAS Registry Mumber 876892-41-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,8,9 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 876892-41:
(8*8)+(7*7)+(6*6)+(5*8)+(4*9)+(3*2)+(2*4)+(1*1)=240
240 % 10 = 0
So 876892-41-0 is a valid CAS Registry Number.

876892-41-0Relevant articles and documents

6-(1-benzyl-1 h -pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach

Costi, Roberta,Métifiot, Mathieu,Esposito, Francesca,Cuzzucoli Crucitti, Giuliana,Pescatori, Luca,Messore, Antonella,Scipione, Luigi,Tortorella, Silvano,Zinzula, Luca,Novellino, Ettore,Pommier, Yves,Tramontano, Enzo,Marchand, Christophe,Di Santo, Roberto

, p. 8588 - 8598 (2013/12/04)

The increasing efficiency of HAART has helped to transform HIV/AIDS into a chronic disease. Still, resistance and drug-drug interactions warrant the development of new anti-HIV agents. We previously discovered hit 6, active against HIV-1 replication and targeting RNase H in vitro. Because of its diketo-acid moiety, we speculated that this chemotype could serve to develop dual inhibitors of both RNase H and integrase. Here, we describe a new series of 1-benzyl-pyrrolyl diketohexenoic derivatives, 7a-y and 8a-y, synthesized following a parallel solution-phase approach. Those 50 analogues have been tested on recombinant enzymes (RNase H and integrase) and in cell-based assays. Approximately half (22) exibited inhibition of HIV replication. Compounds 7b, 7u, and 8g were the most active against the RNase H activity of reverse-transcriptase, with IC50 values of 3, 3, and 2.5 μM, respectively. Compound 8g was also the most potent integrase inhibitor with an IC50 value of 26 nM.

Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H Domain

Santo, R. Di

scheme or table, p. 3335 - 3342 (2012/06/18)

The HIV-1 integrase (IN) and reverse transcriptase (RT) are essential enzymes in the virus cycle. RT is crucial for the retrotranscription of the RNA viral genome, while IN is involved in the insertion in host chromosome of the proviral double strand DNA produced by RT. This enzyme has two associated functions: the RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) and the ribonuclease H (RNase H). The RNase H function catalyzes the selective hydrolysis of the RNA strand of the RNA:DNA heteroduplex replication intermediate. Since the discovery that catalytic cores of both HIV-1 RNase H and IN are folded in a very similar way, have very similar active site geometries, and show the same DDE triad absolutely required for catalytic activity, some researches were devoted to study IN and RNase H dual inhibitor. Our decennial interest in design and synthesis of IN inhibitors led us to study the activity of our compounds also on RNase H activity. The results of the activities showed by pyrrolyl and quinolonyl diketo acids are reported and discussed.

Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity

Di Santo,Costi,Artico,Ragno,Greco,Novellino,Marchand,Pommier

, p. 409 - 417 (2007/10/03)

Highly active anti-retroviral therapy (HAART) using reverse transcriptase (RT) and protease (PR) inhibitors and, more recently, inhibitors of the fusion is currently the best clinical approach in combating acquired immunodeficiency syndrome (AIDS), caused

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 876892-41-0